| Employment |
| No Relationships to Disclose |
|
|
| Leadership |
| No Relationships to Disclose |
|
|
| Stock and Other Ownership Interests |
| No Relationships to Disclose |
|
|
| Honoraria |
| No Relationships to Disclose |
|
|
| Consulting or Advisory Role |
| Company: Amgen |
| Recipient: An Immediate Family Member |
| Company: California Institute for Regenerative Medicine (CIRM) |
| Recipient: An Immediate Family Member |
| Company: IgM Biosciences |
| Recipient: An Immediate Family Member |
| Company: Taiho Oncology |
| Recipient: An Immediate Family Member |
| Company: GlaxoSmithKline |
| Recipient: You |
| Company: natera |
| Recipient: You |
| Company: Janssen Oncology |
| Recipient: You |
| Company: Merck Serono |
| Recipient: You |
| Company: Elevation Oncology |
| Recipient: You |
| Company: Seagen |
| Recipient: You |
| Company: Pfizer |
| Recipient: You |
| Company: Abbvie |
| Recipient: You |
| Company: Hoopika |
| Recipient: You |
| Company: Takeda |
| Recipient: You |
| Company: Elevar |
| Recipient: Your Institution |
| Company: Merck |
| Recipient: Your Institution |
| Company: Pfizer |
| Recipient: Your Institution |
| Company: Gritstone |
| Recipient: Your Institution |
| Company: Sumitomo Dainippon Pharma Oncology |
| Recipient: Your Institution |
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| Company: hutchinson |
| Recipient: Your Institution |
| Company: Merck |
| Recipient: Your Institution |
| Company: Gritstone Bio |
| Recipient: Your Institution |
| Company: Janssen Oncology |
| Recipient: Your Institution |
| Company: Pfizer |
| Recipient: Your Institution |
|
| Patents, Royalties, Other Intellectual Property |
| No Relationships to Disclose |
|
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| No Relationships to Disclose |
|
|
| Other Relationship |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Uncompensated Relationships |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Open Payments Link |
| not answered |
|
|